Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GBIO |
---|---|---|
09:32 ET | 2933 | 3.66 |
09:34 ET | 1999 | 3.7252 |
09:36 ET | 1400 | 3.8 |
09:38 ET | 1769 | 3.7001 |
09:39 ET | 1400 | 3.89 |
09:41 ET | 2100 | 3.91 |
09:43 ET | 1500 | 3.92 |
09:45 ET | 2530 | 3.95 |
09:48 ET | 2467 | 4.09 |
09:50 ET | 6506 | 4.115 |
09:52 ET | 4417 | 4 |
09:54 ET | 4900 | 4.13 |
09:56 ET | 3541 | 4.0071 |
09:57 ET | 1900 | 4.11 |
09:59 ET | 500 | 4.17 |
10:03 ET | 5796 | 4.1 |
10:08 ET | 1471 | 4.0901 |
10:10 ET | 696 | 4.15 |
10:14 ET | 7973 | 4.15 |
10:15 ET | 1240 | 4.13 |
10:17 ET | 1000 | 4.1294 |
10:19 ET | 100 | 4.145 |
10:21 ET | 8123 | 4.1 |
10:30 ET | 5053 | 4.17 |
10:32 ET | 2923 | 4.17 |
10:33 ET | 200 | 4.168 |
10:35 ET | 3322 | 4.23 |
10:37 ET | 7763 | 4.28 |
10:39 ET | 11465 | 4.2615 |
10:42 ET | 1915 | 4.31 |
10:44 ET | 1631 | 4.3 |
10:46 ET | 1351 | 4.26 |
10:50 ET | 4093 | 4.19 |
10:51 ET | 430 | 4.2276 |
10:53 ET | 4543 | 4.1349 |
10:55 ET | 475 | 4.1201 |
10:57 ET | 310 | 4.12 |
11:00 ET | 600 | 4.16 |
11:02 ET | 1481 | 4.145 |
11:08 ET | 2973 | 4.115 |
11:09 ET | 2200 | 4.1101 |
11:13 ET | 1300 | 4.11 |
11:15 ET | 700 | 4.16 |
11:18 ET | 400 | 4.16 |
11:20 ET | 300 | 4.15 |
11:26 ET | 200 | 4.11 |
11:27 ET | 200 | 4.13 |
11:29 ET | 496 | 4.14 |
11:40 ET | 1530 | 4.17 |
11:47 ET | 338 | 4.15 |
11:49 ET | 100 | 4.17 |
11:51 ET | 700 | 4.22 |
11:54 ET | 600 | 4.21 |
11:56 ET | 1432 | 4.21 |
11:58 ET | 1451 | 4.23 |
12:00 ET | 3417 | 4.25 |
12:02 ET | 2407 | 4.1459 |
12:03 ET | 1301 | 4.14 |
12:09 ET | 150 | 4.165 |
12:12 ET | 2596 | 4.2 |
12:14 ET | 400 | 4.2 |
12:16 ET | 817 | 4.196 |
12:21 ET | 100 | 4.16 |
12:23 ET | 1582 | 4.1109 |
12:25 ET | 2800 | 4.1 |
12:30 ET | 100 | 4.09 |
12:32 ET | 100 | 4.08 |
12:38 ET | 100 | 4.08 |
12:39 ET | 1200 | 4.0892 |
12:41 ET | 2379 | 4.12 |
12:45 ET | 1900 | 4.1 |
12:48 ET | 5174 | 4.06 |
12:52 ET | 100 | 4.0601 |
12:54 ET | 300 | 4.09 |
12:57 ET | 200 | 4.07 |
01:06 ET | 1000 | 4.075 |
01:08 ET | 1557 | 4.085 |
01:12 ET | 500 | 4.04 |
01:17 ET | 1483 | 4.04 |
01:24 ET | 400 | 4.03 |
01:28 ET | 2000 | 4.04 |
01:30 ET | 100 | 4.03 |
01:33 ET | 300 | 4.01 |
01:39 ET | 3320 | 4 |
01:42 ET | 3779 | 4 |
01:46 ET | 1100 | 3.96 |
02:00 ET | 200 | 3.93 |
02:02 ET | 596 | 3.9 |
02:04 ET | 200 | 3.9 |
02:06 ET | 232 | 3.889 |
02:08 ET | 2312 | 3.84 |
02:18 ET | 3731 | 3.93 |
02:26 ET | 5757 | 3.89 |
02:27 ET | 700 | 3.9 |
02:29 ET | 200 | 3.93 |
02:31 ET | 100 | 3.925 |
02:33 ET | 100 | 3.93 |
02:36 ET | 900 | 3.9 |
02:38 ET | 396 | 3.9 |
02:47 ET | 500 | 3.895 |
02:51 ET | 1100 | 3.92 |
02:54 ET | 1414 | 3.91 |
02:56 ET | 100 | 3.9 |
02:58 ET | 200 | 3.8925 |
03:00 ET | 1734 | 3.85 |
03:05 ET | 871 | 3.855 |
03:21 ET | 3359 | 3.79 |
03:30 ET | 498 | 3.8 |
03:32 ET | 100 | 3.78 |
03:34 ET | 1300 | 3.8 |
03:36 ET | 623 | 3.81 |
03:38 ET | 200 | 3.83 |
03:39 ET | 400 | 3.81 |
03:41 ET | 1270 | 3.8 |
03:45 ET | 294 | 3.8 |
03:48 ET | 400 | 3.8 |
03:52 ET | 1128 | 3.79 |
03:54 ET | 707 | 3.79 |
03:56 ET | 1087 | 3.78 |
03:57 ET | 908 | 3.79 |
03:59 ET | 4175 | 3.79 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Generation Bio Co | 235.4M | -1.5x | --- |
CervoMed Inc | 203.9M | -39.4x | --- |
Ovid Therapeutics Inc | 228.7M | -4.6x | --- |
Eliem Therapeutics Inc | 229.7M | -6.1x | --- |
Omeros Corp | 243.4M | -1.5x | --- |
bluebird bio Inc | 203.7M | -1.4x | --- |
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $252.1M |
---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 66.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.94 |
EPS | $-2.56 |
Book Value | $3.07 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | 25.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,820.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.